Genes upregulated in the human trabecular meshwork in response to elevated intraocular pressure

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 2, 2000, Pages 352-361

  Gonzalez, Pedro ^a   Epstein, David L ^a   Borrás, Teresa ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ANTERIOR EYE SEGMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CASE REPORT; DNA LIBRARY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; HYPOTHESIS; INTRAOCULAR PRESSURE ABNORMALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHLEMM CANAL; TRABECULAR MESHWORK;

AGED; AGED, 80 AND OVER; DNA PROBES; ENZYMES; EXPRESSED SEQUENCE TAGS; EXTRACELLULAR MATRIX PROTEINS; EYE PROTEINS; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKINS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TACHYKININS; TRABECULAR MESHWORK; UP-REGULATION;

EID: 0033980699     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Quigley HA. Open-angle glaucoma [see comments] [Review; 114 refs]. N Engl J Med. 1993;328:1097-1106.
2. Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol. 1989;107:186-188.
3. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783-801.
4. Lutjen-Drecoll E, Shimizu T, Rohrhach M, Rohen JW. Quantitative analysis of 'plaque material' in the inner- and outer wall of Schlemm's canal in normal- and glaucomatous eyes. Exp Eye Res. 1986;42:443-455.
5. Acott TS. Trahecular extracellular matrix regulation. In: Drance SM, Van Buskirk KM. Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore: Williams & Wilkins; 1992:125-157.
6. VanBuskirk EM, Grant WM. Influence of temperature and the question of involvement of cellular metabolism in aqueous outflow. Am J Ophthalmol. 1974;77:565-572.
7. Grierson I, Lee WR. The fine structure of the trabecular meshwork at graded levels of intraocular pressure. (2) Pressures outside the physiological range (0 and 50 mmHg). Exp Eye Res. 1975;20:523-530.
8. Bill A. The drainage of aqueous humor [Editorial]. Invest Ophthalmol. 1975;14:1-3.
9. Rohen JW, Zypen EVD. The phagocytic activity of the trabecular meshwork endothelium. An electron-microscopic study of the vervet (Cercopithecus aethiops). Graefes Archiv Klin Exp Ophthalmol. 1968;175:143-160.
10. Alvarado J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology. 1984;91:564-579.
11. Epstein DL, Roberts BC, Skinner LL. Nonsulfhydryl-reactive phenoxyacetic acids increase aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 1997;38:1526-1534.
12. Erickson-Lamy K, Schroeder A, Epstein DL. Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells. Invest Ophthalmol Vis Sci. 1992;33:2631-2640.
13. Tamm ER, Flugel C, Stefani FH, Lutjen-Drecoll E. Nerve endings with structural characteristics of mechanoreceptors in the human scleral spur. Invest Ophthalmol Vis Sci. 1994;35:1157-1166.
14. Tamm ER, Lutjen-Drecoll E. Ciliary body. [Review; 201 refs]. Microsc Res Tech. 1996;33:390-439.
15. Gonzalez P, Zigler JS Jr, Epstein DL, Borras T. Identification and isolation of differentially expressed genes from very small tissue samples. BioTechniques. 1999;26:884-892.
16. Johnson DH, Tschumper RC. The effect of organ culture on human trabecular meshwork. Exp Eye Res. 1989;49:113-127.
17. Johnson DH. Human trabecular meshwork cell survival is dependent on perfusion rate. Invest Ophthalmol Vis Sci. 1996;37:1204-1208.
18. Johnson DH, Tschumper RC. Human trabecular meshwork organ culture. A new method. Invest Ophthalmol Vis Sci. 1987;28:945-953.
19. Lennon G, Auffray C. Polymeropoulos M, Soares MB. The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics. 1996;33:151-152.
20. Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun. 1999; 259:523-526.
21. Chiwakata C, Brackmann B, Hunt N, Davidoff M, Schulze W, Ivell R. Tachykinin (suhstance-P) gene expression in Leydig cells of the human and mouse testis. Endocrinology. 1991;128:2441-2448.
22. Krause JE, Chirgwin JM, Carter MS, Xu ZS, Hershey AD. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci USA. 1987;84:881-885.
23. Johnstone MA, Grant WG. Pressure-dependent changes in structures of the aqueous outflow system of human and monkey eyes. Am J Ophthalmol. 1973;75:365-383.
24. Johnstone MA. Pressure-dependent changes in nuclei and the process origins of the endothelial cells lining Schlemm's canal. Invest Ophthalmol Vis Sci. 1979;18:44-51.
25. Tumminia SJ, Milton KP, Arora J, Zelenka P, Epstein DL, Russell P. Mechanical stretch alters the actin cytoskeletal network and signal transduction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1998;39:1361-1371.
26. Borras T, Rowlette LL, Epstein DL. Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther. 1999;6:515-524.
27. Biffl WL, Moore EL, Moore FA, Peterson VM. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation [Review; 256 refs]? Ann Surg. 1996;224:647-664.
28. McGillis JP, Mitsuhashi M, Payan DG. Immunomodulation by tachykinin neuropeptides. [Review; 36 refs]. Ann NY Acad Sci. 1990;594:85-94.
29. de Vries HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol. 1996;64:37-43.
30. Kitamura Y, Morita I, Nihei Z, Mishima Y, Murota S. Effect of IL-6 on tumor cell invasion of vascular endothelial monolayers. Surg Today. 1997;27:534-541.
31. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992;131:710-714.
32. Campbell IL, Abraham CR, Masliah L, et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA. 1993;90:10061-10065.
33. Hirano T, Matsuda T, Turner M. et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol. 1988;18:1797-1801.
34. Thurston G, Baluk P, Hirata A, McDonald DM. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol. 1996;271:H2547-H2562.
35. Duchini A, Govindarajan S, Santucci M, Zampi G, Hofman FM. Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Invest Med. 1996;44:474-482.
36. Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res 1998;76:91-94.
37. Fujita J, Tsujinaka T, Yano M, et al. Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways. Int J Cancer. 1996;68:637-643.
38. Ala Y, Palluy O, Favero J, Bonne C, Modat G, Dornand J. Hypoxia/ reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production. Effects of free radical scavengers. Agents Actions. 1992;37:134-139.
39. Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem. 1988;263: 6177-6182.
40. Ray A, Sassone-Corsi P, Sehgal PB. A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol Cell Biol. 1989;9:5537-5547.
41. McGee DW, Beagley KW, Aicher WK, McGhee JR. Transforming growth factor-beta enhances interleukin-6 secretion by intestinal epithelial cells. Immunology. 1992;77:7-12.
42. Rahman S, Bunning RA, Dobson PR, et al. Bradykinin stimulates the production of prostaglandin E, and interleukin-6 in human osteoblast-like cells. Biochim Biophys Acta. 1992;1135:97-102.
43. Gilabert R, Gasull X, Pales J, Belmonte C, Bergamini MV, Gual A. Facility changes mediated by cAMP in the bovine anterior segment in vitro. Vision Res. 1997;37:9-15.
44. Crawford KS, Gange SJ, Gabelt BT, et al. Indomethacin and epinephrine effects on outflow facility and cyclic adenosine monophosphate formation in monkeys. Invest Ophthalmol Vis Sci. 1996;37:1348-1359.
45. Erickson K, Liang L, Shum P, Nathanson JA. Adrenergic regulation of aqueous outflow. J Ocul Pharmacol. 1994;10:241-252.
46. Lutjen-Drecoll E. Functional morphology of the trabecular meshwork in primate eyes. [Review; 1.36 refs]. Prog Retin Eye Res. 1999;18:91-119.
47. Llobet A, Gual A, Pales J, Barraquer R, Tobias E, Nicolas JM. Bradykinin decreases outflow facility in perfused anterior segments and induces shape changes in passaged BTM cells in vitro. Invest Ophthalmol Vis Sci. 1999;40:113-125.
48. Kimball ES. Substance P, cytokines, and arthritis. [Review; 88 refs]. Ann NY Acad Sci. 1990;594:293-308.
49. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 1988;241:1218-1221.
50. 2+ concentration and inositol phosphate formation. J Immunol. 1988;141:2118-2124.
51. Nakanishi S. Substance P pre-cursor and kininogen: their structures, gene organisations, and regulation. [Review; 74 refs]. Physiol Rev. 1987;67:1117-1142.
52. Aliakbari J, Sreedharan SP, Turck CW, Goetzl EJ. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun. 1987;148:1440-1445.
53. Bost KL, Breeding SA, Pascual DW. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. Reg Immunol. 1992;4:105-112.
54. Lai JP, Douglas SD, Ho WZ. Human lymphocytes express substance P and its receptor. J Neuroimmunol. 1998;86:80-86.
55. Laties AM, Stone RA, Brecha NC. Substance P-like immunoreactive nerve fibers in the trabecular meshwork. Invest Ophthalmol Vis Sci. 1981;21:484-486.
56. Sasamoto M, Chen HB, Tsukahara S. Ultrastructural identification of substance P containing nerves in the guinea pig trabecular meshwork. Ophthalmic Res. 1998;30:127-134.
57. Stone RA, Kuwayama Y. Substance P-like immunoreactive nerves in the human eye. Arch Ophthalmol. 1985;103:1207-1211.
58. Milner P, Kirkpatrick KA, Ralevic V, Toothill V, Pearson J, Burnstock G. Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc R Soc Lond B Biol Sci. 1990;241:245-248.
59. Leber T. Studien uber den Flussigkeitswechsel im Auge. Graefes Arch Ophthalmol. 1873;19:87-91.
60. Hamanaka T, Bill A, Ichinohasama R, Ishida T. Aspects of the development of Schlemm's canal. Exp Eye Res. 1992;55:479-488.
61. Smelser GK, Ozanics V. The development of the trabecular meshwork in primate eyes. Am J Ophthalmol. 1971;1:366-385.
62. Tripathi RC, Tripathi BJ. In: Jacobiec FA, ed. Ocular anatomy, embryology and teratology. Philadelphia: Harper Row; 1982:197-284.
63. Fischer-Colbrie R, Laslop A, Kirchmair R. Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. [Review; 209 refs]. Prog Neurobiol. 1995;46:49-70.
64. Rosa P, Zanini A. Characterization of adenohypophysial polypeptides by two-dimensional gel electrophoresis. II. Sulfated and glycosylated polypeptides. Mol Cell Endocrinol. 1981;24:181-193.
65. Winkler H, Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. [Review; 379 refs]. Neuroscience. 1992;49:497-528.
66. Kirchmair R, Hogue-Angeletti R, Gutierrez J, Fischer-Colbrie R, Winkler H. Secretoneurin - a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience. 1993; 53:359-365.
67. Ortego J, Escribano J, Crabb J, Coca-Prados M. Identification of a neuropeptide and neuropeptide-processing enzymes in aqueous humor confers neuroendocrine features to the human ocular ciliary epithelium. J Neurochem. 1996;66:787-796.
68. Duffy MJ. Proteases as prognostic markers in cancer. [Review; 73 refs]. Clin Cancer Res. 1996;2:613-618.
69. Sharma R, Suzuki K, Nagasc H, Savin VJ. Matrix metalloproteinase (stromelysin-1) increases the albumin permeability of isolated rat glomeruli. J Lab Clin Med. 1996;128:297-303.
70. Huang SM, Adamis AP, Wiederschain DG, Shima DT, Shing Y, Moses MA. Matrix metalloproteinases and their inhibitors in aqueous humor. Exp Eye Res. 1996;62:481-490.
71. Bradley JM, Vranka J, Colvis CM, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
72. Parshley DE, Bradley JM, Samples JR, Van Buskirk EM, Acott TS. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr Eye Res 1995;14:537-544.
73. Sanders MC, Goldstein AL, Wang YL. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Nutl Acad Sci USA. 1992;89:4678-4682.
74. Danowski BA. Fibroblast contractility and actin organization are stimulated by microtubule inhibitors. J Cell Sci. 1989;93:255-266.
75. Tsutsui H, Tagawa H, Kent RL, et al. Role of microtubules in contractile dysfunction of hypertrophied cardiocytes. Circulation. 1994;90:533-555.
76. Epstein DL, Rowlette LL, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40: 74-81.
77. Gills JP, Roberts BC, Epstein DL. Microtubule disruption leads to cellular contraction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1998;39:653-658.
78. da Costa SR, Yarber FA, Zhang L, Sonee M, Hamm-Alvarez SF. Microtubules facilitate the stimulated secretion of beta-hexosaminidase in lacrimal acinar cells. J Cell Sci. 1998;111:1267-1276.
79. Stone EM, Fingert JH, Alward WLM. et al. Identification of a gene that causes primary open angle glaucoma [see comments]. Science 1997;275:668-670.
80. Stamer WD, McKay BS, Roberts BC, Borras T, Epstein DL. Myosin-like domain of TIGR/MYOC targets to vesicles. Invest Ophthalmol Vis Sci. 1998;39:S437.
81. Lutjen-Drecoll K, May CA, Polansky JR, Johnson DH, Bloemendal H, Nguyen TD. Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork. Invest Ophthalmol Vis Sci. 1998;39:517-525.
82. Tamm ER, Russell P, Johnson DH, Piatigorsky J. Human and monkey trabecular meshwork accumulate alpha B-crystallin in response to heat shock and oxidative stress. Invest Ophthalmol Vis Sci. 1996;37:2402-2413.
83. Mitton KP, Tumminia SJ, Arora J, Zelenka P, Epstein DL, Russell P. Transient loss of alphaB-crystallin: an early cellular response to mechanical stretch. Biochem Biophys Res Commun. 1997;235:69-73.
84. Ito Y, Pagano PJ, Tornheim K, Brecher P, Cohen KA. Oxidative stress increases glyceraldehyde-3-phosphate dehydrogenase mRMA levels in isolated rabbit aorta. Am J Physiol. 1996;270:H81-H87.
85. Palmiter RD. Molecular biology of metallothionein gene expression. [Review; 93 refs]. EXS. 1987;52:63-80.
86. Andrews GK. Regulation of metallothionein gene expression [Review; 272 refs]. Prog Food Nutr Sci. 1990;14:193-258.
87. Min KS, Terano Y, Onosaka S, Tanaka K. Induction of hepatic metallothionein by nonmetallic compounds associated with acute-phase response in inflammation Toxicol Appl Pharmacol. 1991; 111:152-162.
88. Bauman JW, Madhu C, McKim JM Jr, Liu Y, Klaassen CD. Induction of hepatic metallothionein by paraquat. Toxicol Appl Pharmacol. 1992;117:233-241.
89. Michiels C, Raes M, Toussaint O, Remacle J. Importance of Seglutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidutive stress. [Review; 110 refs]. Free Radic Biol Med. 1994;17:235-248.
90. Freedman SF, Anderson PJ, Epstein DL. Superoxide dismutase and catalase of calf trabecular meshwork. Invest Ophthalmol Vis Sci. 1985;26:1330-1335.
91. De La Paz MA, Epstein DL. Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest Ophthalmol Vis Sci. 1996;37:1849-1853.
92. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 1998;82: 1094-1101.
93. Howard AB, Alexander RW, Nerem RM, Griendling KK, Taylor WR. Cyclic strain induces an oxidative stress in endothelial cells Am J Physiol. 1997;272:C421-C427.
94. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res. 1997;81:1-7.
95. Hsieh HJ, Cheng CC, Wu ST, Chiu JJ, Wung BS, Wang DL. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression. J Cell Physiol. 1998;175:156-162.
96. Cheng JJ, Wung HS, Chao YJ, Wang DL. Cyclic strain-induced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells. Hypertension. 1998;31:125-130.
97. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science. 1998;280:898-902.
98. 2 and genistein differentially modulate protein tyrosine phosphorylation, endothelial morphology, and monolayer barrier function. Biochem Biophys Res Commun. 1998;249(19):461-466.
99. Yan DB, Trope GE, Eithier CR, Menon IA, Wakeham A. Effects of hydrogen peroxide-induced oxidative damage on outflow facility and washout in pig eyes. Invest Ophthalmol Vis Sci. 1991;32: 2515-2520.